LORDSCHLONSELords Chloro Alkali Limited· Chemicals & PetrochemicalsHighNeutral
Announced Mon, 9 Feb, 2026 · 18:42 IST

Lords Chloro Alkali Q3 FY26 results, Rs 42.7 Cr warrant conversion

Revenue Growth 20pctPat Growth 25pctRelated Party TransactionsResults View source PDFExplain this filing

LORDSCHLO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.9%Reaction day
₹154.08
prior close
₹155.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+1.0%-6.9% vs market
Commodity Chemicals peers, median of 53sector+0.3%-6.2% vs sector

On the reaction day the stock moved 6.9 pts less than Nifty Microcap 250 and 6.2 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-3.9
10m
-4.2
15m
-4.2
30m
-5.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.9+1.0-6.9+0.3-6.2
Next day
-8.6+0.5-9.1-0.3-8.3
2d
-10.1-0.0-10.1-0.4-9.8
3d
-8.2-1.5-6.8-1.6-6.7
4d
-12.4-2.2-10.2-2.7-9.7
5d
-15.8-1.2-14.5-3.0-12.7
1w
-18.1-2.4-15.8-3.5-14.6
15d
-19.3-8.8-10.5-7.6-11.7
1m
-20.2-8.3-11.9-9.4-10.7
2m
-0.1-3.5+3.5-5.9+5.8
3m
-5.5+6.4-11.9+2.5-8.0
UpDownMarket · Nifty Microcap 250Sector · Commodity Chemicals peers, median of 53Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Lords Chloro Alkali posted strong Q3 FY26 results. Revenue from operations rose to Rs 93.95 Cr from Rs 65.58 Cr YoY, up 43 percent. PAT climbed to Rs 4.61 Cr from Rs 1.27 Cr. For 9M FY26, revenue grew to Rs 292.49 Cr from Rs 190.44 Cr, and PAT surged to Rs 24.10 Cr from Rs 3.58 Cr. Board approved conversion of 35 lakh warrants at Rs 122 each, raising Rs 42.70 Cr. MD reappointed for 5 years. ESOP and EGM on 18 March 2026 approved.

Likely market impact

Strong Q3 with 43 percent revenue growth and 3.6 times PAT jump. Rs 42.7 Cr raised via warrant conversion. Promoter holding rises slightly to 74.97 percent.